Department of Energy (DOE) national laboratories, like Lawrence Livermore (LLNL), offer unique opportunities to collaborate on and license scientific breakthroughs with market potential.
In its Fiscal Year 2024 (FY24) Technology Transfer Annual Report, LLNL highlights how industry partnerships accelerate innovation and deliver real-world impact.
In FY24, LLNL reported 201 total copyrights, filed 134 U.S. patents and recorded 119 new invention disclosures - illustrating the Laboratory's pipeline of cutting-edge technologies, available for partnership, stemming from its mission-based research. Of the 13 new Cooperative Research & Development Agreements (CRADAs), 10 were with small businesses. Overall, LLNL's 59 active CRADAs in FY24 brought in $7.4 million of partner funds for collaborative research efforts with industry in a variety of areas.
Technology transfer at LLNL is facilitated by the Innovation and Partnerships Office (IPO), which produces the report each year.
One of the standout FY24 success stories: LLNL's collaboration with BridgeBio Oncology Therapeutics. Leveraging LLNL's supercomputing and AI platforms, the partnership advanced two first-in-class cancer drug candidates to Phase I clinical trials - a first for a DOE national laboratory and a testament to the impact of public-private collaboration.
LLNL's IPO also launched a Software Licensing Portal, which makes it easier for industry partners to access and commercialize Laboratory-developed software. Check out the full report here for more on IPO's key FY24 organizational updates to streamline partnership agreements as well as LLNL's other tech-transfer success stories in healthcare, advanced manufacturing, space and fusion.
